Non-steatotic chronic liver disease

1 paper2 findings

Humans1

Upstream

1

Frailty

mediatesin humans1

1 study

Frailty mediates non-steatotic chronic liver disease in humans (4.82% mediated).
Humansassociation between CMM trajectories and incident NSCLDn = 8,310
Cardiometabolic multimorbidity trajectories and incident non-steatotic chronic liver disease in middle-aged and older adults
Nutrition, metabolism, and cardiovascular diseases : NMCD4 Aug 2026

Associations

1

Cardiometabolic multimorbidity

upin humans1HR 2.34

1 study

Cardiometabolic multimorbidity raises the risk of non-steatotic chronic liver disease in humans (HR 2.34 in low PEF% predicted).
Humanscardiometabolic multimorbidity trajectoryn = 8,310
Cardiometabolic multimorbidity trajectories and incident non-steatotic chronic liver disease in middle-aged and older adults
Nutrition, metabolism, and cardiovascular diseases : NMCD4 Aug 2026

More on Cardiometabolic multimorbidity

Latest

1 in 12 months

Nutrition, Metabolism, and Cardiovascular Diseases20 Aug

Cardiometabolic multimorbidity trajectories and incident non-steatotic chronic liver disease in middle-aged and older adults

Cohort study of 8,310 peoplePopulations